Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes (Q33539531)

27 July 2017

Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes (English)

1 reference

27 July 2017

0 references

1 reference

Lea T Drye

3

0 references

Constantine G. Lyketsos

12

object named as

Constantine G Lyketsos

1 reference

27 July 2017

9

Peter V Rabins

1 reference

27 July 2017

2

Paul B Rosenberg

1 reference

27 July 2017

Daniel Weintraub

1

1 reference

27 July 2017

Barbara K Martin

4

1 reference

27 July 2017

Constantine Frangakis

5

1 reference

27 July 2017

Jacobo E Mintzer

6

1 reference

27 July 2017

Anton P Porsteinsson

7

1 reference

27 July 2017

Lon S Schneider

8

1 reference

27 July 2017

Cynthia A Munro

10

1 reference

27 July 2017

Curtis L Meinert

11

1 reference

27 July 2017

DIADS-2 Research Group

13

1 reference

27 July 2017

1 April 2010

1 reference

American Journal of Geriatric Psychiatry

27 July 2017

1 reference

27 July 2017

18

1 reference

27 July 2017

4

1 reference

27 July 2017

332-340

1 reference

Observed association between antidepressant use and pneumonia risk was confounded by comorbidity measures

27 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849739

Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849739

Efficacy and safety of antidepressants for treatment of depression in Alzheimer's disease: a metaanalysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849739

Treatment with antidepressants in patients with dementia--a nationwide register-based study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849739

Research consent for cognitively impaired adults: recommendations for institutional review boards and investigators

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849739

Provisional diagnostic criteria for depression of Alzheimer disease: rationale and background

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849739

Provisional diagnostic criteria for depression of Alzheimer disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849739

Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849739

An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849739

Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849739

A double-blind placebo-controlled study of clomipramine in depressed patients with Alzheimer's disease.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849739

The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849739

Cornell Scale for Depression in Dementia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849739

The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders. A Nordic multicentre study.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849739

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849739

Long-term effects of antidepressants on cognition in patients with Alzheimer's disease.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849739

Design of Depression in Alzheimer's Disease Study-2.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849739

The persistence of neuropsychiatric symptoms in dementia: the Cache County Study.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849739

Treating depression in Alzheimer disease: efficacy and safety of sertraline therapy, and the benefits of depression reduction: the DIADS.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849739

Acute eosinophilic pneumonia associated to sertraline

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849739

Neuropsychiatric disturbance in Alzheimer's disease clusters into three groups: the Cache County study.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849739

A double-blind, placebo-controlled study of fluoxetine in depressed patients with Alzheimer's disease.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849739

A controlled clinical trial of sertraline in the treatment of depression in nursing home patients with late-stage Alzheimer's disease.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849739

Moclobemide in elderly patients with cognitive decline and depression: an international double-blind, placebo-controlled trial.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2849739

Depression, cognitive impairment and function in Alzheimer's disease

31 October 2018

1 reference

12 December 2020

Assessing quality of life in older adults with cognitive impairment

1 reference

12 December 2020

[Carer's burden and depressive symptoms in patients with Alzheimer s disease. State after twelve months]

1 reference

12 December 2020

Double-blind trial of imipramine in Alzheimer's disease patients with and without depression

1 reference

12 December 2020

10.1097/JGP.0B013E3181CC0333

Identifiers

DOI

1 reference

27 July 2017

1 reference

27 July 2017

1 reference